POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Clinical trials for POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER explained in plain language.
Never miss a new study
Get alerted when new POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER trials appear
Sign up with your email to follow new studies for POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New chemo approach tested in kids with tough cancers
Disease control CompletedThis early-phase study tested the safety of a modified chemotherapy regimen, called dose-adjusted EPOCH-R, in children with aggressive B-cell cancers like diffuse large B-cell lymphoma. The treatment involved giving some drugs as a continuous infusion over four days and adjusting…
Matched conditions: POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Phase: EARLY_PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Virus tracking study aims to protect transplant patients from cancer risk
Knowledge-focused CompletedThis study followed 509 kidney transplant patients to understand how monitoring Epstein-Barr virus (EBV) levels might help predict serious risks. Researchers tracked patients' blood for persistent EBV infection to see if it signaled a higher chance of developing certain cancers, …
Matched conditions: POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER
Sponsor: University of Aarhus • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC